1-20 of 61
Plasma Cell Disorders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

Open Access
Clinical Trials & Observations
Andrew R. Branagan, Clifton Mo, Matthew Lei, Joshua N. Gustine, Andrew J. Yee, Elizabeth O’Donnell, Jorge J. Castillo, Omar Nadeem, Catherine Flynn, Zachary Bernstein, Rie Nakamoto-Matsubara, Kirsten Meid, Rakesh Verma, Zachary R. Hunter, Maria L. Guerrera, Galit Alter, Jill Burke, Cynthia Harrington, Emerentia Agyemang, Marilyn Gammon, Kathleen Lively, Lisette Packer, Nora Horick, Jacob Laubach, Constantine S. Mitsiades, Nikhil Munshi, Kenneth C. Anderson, Steven P. Treon, Paul G. Richardson, Noopur S. Raje, Shayna R. Sarosiek
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4568–4579.
https://doi.org/10.1182/bloodadvances.2025016513
Published: 2025
Journal Articles

Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma

Open Access
Clinical Trials & Observations
Xian G. Zhang, Lin Wang, Junfang Yang, Xiaona N. Hu, Hui Wang, Lina N. Zhang, Xiaoge Zhou, Ying Liu, Qinglong Wang, Peihua H. Lu
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4543–4552.
https://doi.org/10.1182/bloodadvances.2025016322
Published: 2025
Includes: Supplemental data
Journal Articles

Sequential BCMA CAR T-cell therapy in refractory multiple myeloma

Open Access
Tim Richardson, Udo Holtick, Jan-Hendrik Frenking, Hishan Tharmaseelan, Hyatt Balke-Want, Ruth Flümann, Elias Karl Mai, Sandra Sauer, Raphael Teipel, Malte von Bonin, Michael Hallek, Christof Scheid, Philipp Gödel
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4624–4630.
https://doi.org/10.1182/bloodadvances.2025016712
Published: 2025
Journal Articles

Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma

Open Access
Maria Teresa Bilotta, Antonio Giovanni Solimando, Prof., Vanessa Desantis, Lucia Di Marzo, Andrea Sabatini, Sergio Forcelloni, Alessandro Andriano, Arcangelo Morizio, Antonella Argentiero, Roberto Ria, Linda Quatrini, Lorenzo Moretta, Paola Vacca, Nicola Tumino
Journal: Blood Advances
Blood Adv bloodadvances.2025016659.
https://doi.org/10.1182/bloodadvances.2025016659
Published: 2025
Includes: Supplemental data
Journal Articles

Patterns of progression among 427 patients with smoldering myeloma diagnosed after 2014: importance of monitoring

Open Access
Efstathios Kastritis, Irene Solia, Panagiotis Malandrakis, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Nikoleta Kokkali, Asimina Papanikolaou, Stavroula Giannouli, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4444–4447.
https://doi.org/10.1182/bloodadvances.2025016083
Published: 2025
Includes: Supplemental data
Journal Articles

Fifteen year of use of functional imaging in multiple myeloma: where we started from and where are we going

Open Access
Elena Zamagni, Marco Talarico
Journal: Blood Advances
Blood Adv bloodadvances.2024015686.
https://doi.org/10.1182/bloodadvances.2024015686
Published: 2025
Journal Articles

Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell Leukemia

Open Access
Gliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, Andre De Menezes Silva Corraes, Vanna Hovanky, Leyla Shune, Joseph P. McGuirk, Gabriel de Avila, Jack Khouri, Danai Dima, Mahmoud R. Gaballa, Binod Dhakal, Peter A Forsberg, Amandeep Godara, Aimaz Afrough, Larry D. Anderson, Jr., Megan M. Herr, James A Davis, Hashim Mann, Sneha Purvey, William Bennett Clark, Myo Myo Htut, Amer M. Beitinjaneh, Denise L. Pereira, Mehmet Kocoglu, Christopher J Ferreri, Shebli Atrash, Peter M Voorhees, Adriana C Rossi, Shambavi Richard, Hamza Hashmi, Krina K. Patel, Surbhi Sidana, Yi Lin, Doris K Hansen, Douglas W Sborov
Journal: Blood Advances
Blood Adv bloodadvances.2025016966.
https://doi.org/10.1182/bloodadvances.2025016966
Published: 2025
Includes: Supplemental data
Journal Articles

Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging

Open Access
Carolina Schinke, Leo Rasche, Cody Ashby, Rudy van Hemert, Sharmilan Thanendrarajan, Samer Al Hadidi, Maurizio Zangari, Clyde Bailey, Daisy V. Alapat, John D. Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Frits van Rhee, Niels Weinhold
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4368–4377.
https://doi.org/10.1182/bloodadvances.2025016510
Published: 2025
Includes: Supplemental data
Journal Articles

Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

Open Access
Jon Thorir Oskarsson, Sigrún Thorsteinsdóttir, Sæmundur Rögnvaldsson, Andri Ólafsson, Gunnhildur Viðarsdóttir, Elfa Rún Guðmundsdóttir, Elias Eythorsson, Asbjorn Jonsson, Bryjnar Vidarsson, Pall T Onundarson, Bjarni A Agnarsson, Margret Sigurdardottir, Ingunn Þorsteinsdóttir, Isleifur Olafsson, Stephen Harding, Brian G.M. Durie, Thorvardur Jon Love, Sigurdur Yngvi Kristinsson
Journal: Blood Advances
Blood Adv bloodadvances.2025017270.
https://doi.org/10.1182/bloodadvances.2025017270
Published: 2025
Journal Articles

From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis

Open Access
Clinical Trials & Observations
Eli Muchtar, Angela Dispenzieri, Francis K. Buadi, Prashant Kapoor, David Dingli, Taxiarchis V. Kourelis, Wilson Gonsalves, Nelson Leung, Suzanne R. Hayman, Martha Q. Lacy, Mustaqeem Siddiqui, Joselle Cook, Nadine Abdallah, Moritz Binder, Saurabh Zanwar, William Hogan, Rahma Warsame, S. Vincent Rajkumar, Shaji K. Kumar, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4311–4316.
https://doi.org/10.1182/bloodadvances.2025016586
Published: 2025
Includes: Supplemental data
Journal Articles

Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma

Open Access
Robbe Heestermans, Catharina Olsen, Shervine Ameli, Jana Succari, Toon Janssen, Wouter De Brouwer, Ann De Becker, Isabelle Vande Broek, Marleen Bakkus, Rik Schots, Elke De Bruyne, Ivan Van Riet
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4306–4310.
https://doi.org/10.1182/bloodadvances.2025016480
Published: 2025
Includes: Supplemental data
Journal Articles

Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy

Open Access
Clinical Trials & Observations
Jessica S. Little, Angelica Medina Pena, E. Bridget Kim, Andrew J. Yee, Omar Nadeem, Shonali Midha, Adam S. Sperling, Nikhil C. Munshi, Noopur Raje, Matthew J. Frigault, Diana D. Cirstea, Sarah P. Hammond
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4190–4194.
https://doi.org/10.1182/bloodadvances.2025016748
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

Open Access
Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S. Firestone, Eric M. Jurgens, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Andriy Derkach, David Nemirovsky, Sergio A. Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi
Journal: Blood Advances
Blood Adv (2025) 9 (15): 4016–4022.
https://doi.org/10.1182/bloodadvances.2025015973
Published: 2025
Journal Articles

Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations

Open Access
Saurabh Zanwar, Joseph Novak, Wilson Gonsalves, Michael Howe, Esteban Braggio, S. Vincent Rajkumar, Moritz Binder, Dragan Jevremovic, Surendra Dasari, Shaji Kumar
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3979–3987.
https://doi.org/10.1182/bloodadvances.2025016619
Published: 2025
Includes: Supplemental data
Journal Articles

Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection

Open Access
Ilske Oschlies, Julia Richter, Amelie Alfert, Fernando Chahud, Stephanie Mueller, Ingrid Simonitsch-Klupp, Hannah von Mersi, Andishe Attarbaschi, Karoline Koch, Christoph Schaefers, Monika Brüggemann, Cecilia Bozzetti, Wilhelm Woessmann, Birgit Burkhardt, Wolfram Klapper
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3909–3918.
https://doi.org/10.1182/bloodadvances.2025016596
Published: 2025
Includes: Supplemental data
Journal Articles

Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy

Open Access
Snegha Ananth, Nancy Eunice Torres, Bita Sahaf, Lekha Mikkilineni, Sebastian Fernandez-Pol, Darren Salmi, Robert Negrin, Parveen Shiraz, Melody Smith, Sushma Bharadwaj, Wen-Kai Weng, Vanessa E. Kennedy, Saurabh Dahiya, Lori Muffly, David Miklos, Matthew J. Frank, Hitomi Hosoya, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3832–3836.
https://doi.org/10.1182/bloodadvances.2025016346
Published: 2025
Includes: Supplemental data
Journal Articles

Predictive value of free light chain burden in patients with AL amyloidosis treated with bortezomib-based regimens

Open Access
Brendan Saunders, Foteini Theodorakakou, Despina Fotiou, Samuel Boullt, Benjamin Evans, Meletios A. Dimopoulos, Efstathios Kastritis, Giada Bianchi
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3771–3779.
https://doi.org/10.1182/bloodadvances.2024015528
Published: 2025
Includes: Supplemental data
Journal Articles

IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels

Open Access
Rahul Banerjee, Meera Mohan, Kai Rejeski, Benjamin R. Puliafito, Diana D. Cirstea, Gurbakhash Kaur, Shonali Midha, Georgia J McCaughan, Nikhil M Kumar, Nikita Mehra, Bhausaheb Bagal, Noopur S. Raje
Journal: Blood Advances
Blood Adv bloodadvances.2025016490.
https://doi.org/10.1182/bloodadvances.2025016490
Published: 2025
Journal Articles

The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia

Open Access
Asis Shrestha, Sharmilan Thanendrarajan, Aishee Bag, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Frits van Rhee, Anita D'Souza, Nishi Shah, Mansi R. Shah, Meera Mohan, Carolina Schinke
Journal: Blood Advances
Blood Adv bloodadvances.2025016695.
https://doi.org/10.1182/bloodadvances.2025016695
Published: 2025
Journal Articles

Can baseline Cytomegalovirus IgG titers predict Cytomegalovirus reactivation after ide-cel therapy?

Open Access
Taku Kikuchi, Ukyo Kondo, Shotaro Sugita, Miyu Watanabe, Chiaki Matsumoto, Moe Yogo, Kodai Kunisada, Haruka Sawada, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Osamu Hosoya, Tadao Ishida, Nobuhiro Tsukada
Journal: Blood Advances
Blood Adv bloodadvances.2025017174.
https://doi.org/10.1182/bloodadvances.2025017174
Published: 2025
Includes: Supplemental data